Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
- Resource Type
- Article
- Source
- In
The Lancet 2008 371(9618):1073-1084 - Subject
Primary Research Articles - Language
- ISSN
- 0140-6736